These findings suggest that KRFK TFA partially reverse inhibitory effect fruquintinib on CRC cell migration and invasion, highlighting the critical role of the TGF-β/Smad pathway in mediating fruquintinib’s mechanism of action. Here, TGFB1 is linked to colorectal carcinoma.